Peptide Capsules for Sale in Australia
| Product | Per capsule | Bottle | Also sold as |
|---|---|---|---|
| BPC-157 capsules | 500 mcg | 60 capsules, child-resistant cap | 10 mg lyophilized vial |
| SLU-PP-332 capsules | 250 mcg | 60 capsules, child-resistant cap | 5 mg lyophilized vial |
Both bottles are labelled with lot number and expiry. Store them closed, below 25 °C, somewhere dry and dark, since moisture is what degrades a solid format.
Why BPC-157 Capsules Exist
Most peptides are broken down in the stomach, which is why nearly everything in this field is sold as an injectable vial. BPC-157 is the exception. It is a 15 amino acid sequence (GEPPPGKPADDAGLV) taken from a protein in human gastric juice, and Professor Predrag Sikiric's group in Zagreb describes it as a "stable gastric pentadecapeptide" that remains intact in human gastric juice for more than 24 hours. Their rat studies have given it orally in drinking water as well as by injection.
That stability is the reason BPC 157 capsules are a legitimate research format rather than a novelty, and the reason we supply BPC-157 as capsules at all.
BPC 157 Capsules Australia: What You Receive
Each bottle holds 60 capsules of 500 mcg BPC-157 under a white child-resistant cap. The capsules need no reconstitution and no diluent, which suits study designs that call for a fixed, pre-measured oral amount. For work in solution, where you set the concentration, the 10 mg BPC-157 vial is the better choice.
BPC-157 has been listed in Schedule 4 of the Poisons Standard since 1 June 2024 and is named in the TGA's April 2026 safety alert on unapproved peptides. Our guide on what BPC-157 is covers its research history.
SLU-PP-332 Capsules: Read This Before You Order
SLU-PP-332 is a small-molecule agonist of the estrogen-related receptors ERR alpha, beta and gamma, not a peptide. We sell it as capsules because it is stable as a dry solid, but stability on the shelf is not the same as absorption. In a 2026 paper in the Journal of Pharmacology and Experimental Therapeutics (Billon, Appourchaux, Côté and Burris), the laboratory that developed SLU-PP-332 states that it lacks oral bioavailability, and presents SLU-PP-915 as an orally active successor.
Our recommendation: for most work, choose the 5 mg SLU-PP-332 vial rather than the capsules, and buy the capsules only when your design specifically needs to examine the oral route. We compare the two in SLU-PP-332 capsules vs vial, and the compound itself in what is SLU-PP-332.
BPC-157 TB-500 Capsules and Other Capsules We Do Not Sell
Chainwell Peptide does not sell BPC-157 and TB-500 capsules. TB-500 has no gastric-stability data comparable to BPC-157's, so we supply the pair only as the Wolverine Blend vial, or as separate TB-500 and BPC-157 vials. We also do not sell TB-500, KPV or GHK-Cu as capsules; all three are vial-only in our tissue repair and skin ranges.
Capsules or Vial?
| Capsules | Lyophilized vial | |
|---|---|---|
| Form | Pre-measured solid | Freeze-dried powder |
| Preparation | None | Reconstitute with bacteriostatic water |
| Amount | Fixed per capsule | Concentration set by diluent volume |
| Storage | Below 25 °C, dry and dark | Minus 20 °C long term; 2 to 8 °C once mixed |
| Makes sense for | BPC-157 oral-route studies | Everything else |
Tested Lots, Tracked Delivery
Every capsule lot is tested by an independent laboratory for identity by mass spectrometry and purity by HPLC, and the lot number on the bottle matches its certificate on the COA lookup page; see quality and testing. Orders paid by PayID or bank transfer before 3pm AEST on a business day are dispatched the same day from within Australia by tracked standard or express post, as set out in the shipping policy. Volume buyers can use wholesale.
Capsules are supplied for laboratory research use only, not for human or veterinary use, and we do not give dosing advice.
Frequently asked questions
Do you sell BPC 157 capsules in Australia?
+
Yes. Chainwell Peptide sells BPC-157 capsules at 500 mcg each, 60 per bottle, dispatched from within Australia by tracked post. Each lot is tested by an independent laboratory for identity and purity, and its certificate can be checked on the COA lookup page. BPC-157 is also sold as a 10 mg vial.
Why can BPC-157 be made into a capsule when most peptides cannot?
+
Because BPC-157 is unusually stable in stomach conditions. It comes from a protein in human gastric juice, and published work from Sikiric's group reports it staying intact in human gastric juice for more than 24 hours, whereas most peptides are quickly broken down there.
Are SLU-PP-332 capsules orally bioavailable?
+
According to its developers, no. A 2026 paper from the Burris laboratory in the Journal of Pharmacology and Experimental Therapeutics states that SLU-PP-332 lacks oral bioavailability. For most research the 5 mg vial is the better choice, and the capsules suit only studies that set out to examine the oral route.
Do you sell BPC-157 and TB-500 capsules?
+
No. Chainwell Peptide does not sell a BPC-157 and TB-500 capsule. The two are available together as the Wolverine Blend, a 10 mg lyophilized vial, or as separate BPC-157 and TB-500 vials. BPC-157 on its own is available as capsules.





